Our Services
Medical Information
Helpful Resources
Published on: 6/14/2026
High calcium and high PTH on routine blood tests typically point to primary hyperparathyroidism. To confirm the diagnosis, doctors will repeat labs, evaluate vitamin D levels, kidney function, and urinary calcium, and review your symptoms and risk factors. Imaging studies and a bone density (DEXA) scan are also commonly ordered to assess the impact on bones and kidneys.
Treatment depends on severity and may include:
Several individual factors influence the right path forward; see below for complete details.
Because high calcium combined with high PTH can quietly affect your bones, kidneys, and energy levels long before serious symptoms appear, understanding your specific situation early is critical. A free, instant, online symptom check can help you clarify what your labs and symptoms may mean, identify red flags, and guide your next conversation with your doctor — all in just a few minutes, with no cost or commitment.
Reviewed for medical accuracy: 06/14/2026
When routine blood tests show both calcium and parathyroid hormone (PTH) levels above normal, doctors suspect hyperparathyroidism. This condition arises when one or more of your parathyroid glands—tiny glands in your neck—produce too much PTH. Excess PTH causes calcium to rise in your blood, which can affect bones, kidneys and other organs. Here's what you can expect next.
Parathyroid hormone helps regulate calcium and phosphorus in your body. When PTH is too high:
Over time, that extra calcium can damage:
Doctors classify hyperparathyroidism as:
This guide focuses on primary hyperparathyroidism, the most common form with both calcium and PTH high.
Normally, high blood calcium suppresses PTH release. In primary hyperparathyroidism that feedback loop breaks due to gland overactivity:
Persistently high calcium can cause:
Early stages may be mild or asymptomatic, so your doctor will rely on labs and further testing.
When labs confirm elevated calcium and PTH, your physician will usually:
These steps help confirm primary hyperparathyroidism, rule out secondary causes (like vitamin D deficiency or kidney disease) and guide treatment.
Treatment depends on symptom severity, lab results and overall health. Options include:
For mild cases with minimal symptoms, your doctor may recommend:
This approach is safe if you remain symptom-free and labs stay stable.
Surgical removal of the overactive gland(s) is the only cure for primary hyperparathyroidism. It's generally recommended when:
Surgery has high success rates (>95%) when performed by an experienced surgeon. Risks include:
If you're not a candidate for surgery, doctors may prescribe:
These are not cures but can control symptoms and biochemical changes.
Beyond specific treatments, self-care and lifestyle measures make a difference:
Regular follow-up is key. Even if you feel fine, complications can develop silently.
If you have any of the following, contact your doctor right away:
Always speak to a doctor about any life-threatening or serious symptoms.
If you're experiencing symptoms and want to better understand your condition before your doctor visit, you can use Ubie's free AI-powered Hyperparathyroidism symptom checker to get personalized insights in just a few minutes.
Managing hyperparathyroidism often involves a team:
Keep a clear record of your lab values, imaging studies and symptoms. Ask questions like:
Remember—early detection and appropriate treatment of hyperparathyroidism protect your bones, kidneys and heart. If in doubt, always speak to a doctor about any serious or life-threatening concerns.
(References)
* Staub, R. E., & Darden, M. (2023). Primary Hyperparathyroidism: A Comprehensive Review. Missouri Medicine, 120(6), 560-566.
* Bilezikian, J. P., Brandi, M. L., Eastell, R., Silverberg, S. J., Udelsman, A., Marcocci, R., & Potts, J. T., Jr (2022). Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop. Journal of Bone and Mineral Research, 37(1), 1-10.
* Eastell, R., & Brandi, M. L. (2022). Primary hyperparathyroidism. The Lancet, 399(10334), 1583-1595.
* Pitt, S. C., & Sippel, R. S. (2022). Primary Hyperparathyroidism: Best Practice. Surgical Oncology Clinics of North America, 31(1), 37-46.
* Marcocci, C., Cetani, F., & Bilezikian, J. P. (2023). Management of Primary Hyperparathyroidism. Endocrine Reviews, 44(2), 246-271.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.